共 50 条
- [28] Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: An open-label, randomised, crossover, controlled trial [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (05): : 713 - 720